{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:12:27Z","timestamp":1791918747349,"version":"4.3.4"},"reference-count":36,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,2,3]],"date-time":"2009-02-03T00:00:00Z","timestamp":1233619200000},"content-version":"vor","delay-in-days":4416,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Cardiology"],"published-print":{"date-parts":[[1997,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Advances in the understanding of the biochemistry of the mechanism of hemostasis have led to the development of sensitive methods for determining levels of markers which reflect thrombin activity (thrombin\u2010antithrombin III complex, fibrinopeptide A, F1+2 fragment), active fibrinolysis (D\u2010dimer, plasmin\u2010\u03b12\u2010plasmin inhibitor complex), and platelet activity (platelet factor 4, \u00df\u2010thromboglobulin) in vivo. Measurement of these markers may be useful in identifying patients with various cardiovascular disorders at high risk of thromboembolism.<\/jats:p>","DOI":"10.1002\/clc.4960200104","type":"journal-article","created":{"date-parts":[[2009,2,4]],"date-time":"2009-02-04T01:10:45Z","timestamp":1233709845000},"page":"7-10","source":"Crossref","is-referenced-by-count":25,"title":["Biochemical markers of coagulation activation in mitral stenosis, atrial fibrillation, and cardiomyopathy"],"prefix":"10.1002","volume":"20","author":[{"given":"Uichi","family":"Ikeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,2,3]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"71","article-title":"Laboratory markers of coagulation activation","volume":"117","author":"Bauer KA","year":"1993","journal-title":"Arch Pathol Lab Med"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)00322-H"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(92)90062-4"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(79)90286-X"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/91.1.82"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)92158-X"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199203040-00015"},{"key":"e_1_2_1_9_2","first-page":"311A","article-title":"Thrombin activation in dilated cardiomyopathy","volume":"21","author":"Jung SC","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.45.4.878"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.43.3.301"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.32.1.26"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5392.1209"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-52-4-741"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1986.00520010065026"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-0620(60)80009-6"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.47.551.599"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.28.10.973"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.37.4.378"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(86)80006-7"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(73)92730-X"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.15.2.282"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.26.4.544"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(81)90534-8"},{"key":"e_1_2_1_25_2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1055\/s-0038-1657888","article-title":"Prevention of arterial and pulmonary embolism by oral anticoagulants in patients with dilated cardiomyopathy","volume":"54","author":"Kyrle PA","year":"1985","journal-title":"Thromb Haemostas"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(83)90588-X"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(87)90618-7"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(93)90022-2"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(95)00049-A"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.14.4.530"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.14.5.668"},{"key":"e_1_2_1_32_2","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1056\/NEJM199011293232201","article-title":"The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators: The effect of low\u2010dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation","volume":"323","year":"1990","journal-title":"N Engl J Med"},{"key":"e_1_2_1_33_2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0735-1097(91)90585-W","article-title":"Canadian Atrial Fibrillation Anticoagulation (CAFAS) Study","volume":"18","author":"Connolly SJ","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199211123272002"},{"key":"e_1_2_1_35_2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(89)91200-2","article-title":"Placebo\u2010controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: The Copenhagen AFASAK study","volume":"1","author":"Petersen P","year":"1989","journal-title":"Lancet"},{"key":"e_1_2_1_36_2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/01.CIR.84.2.527","article-title":"Stroke Prevention in Atrial Fibrillation Investigators: Stroke Prevention in Atrial Fibrillation Study: Final results","volume":"84","year":"1991","journal-title":"Circulation"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(97)89351-4"}],"container-title":["Clinical Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fclc.4960200104","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/clc.4960200104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T14:07:18Z","timestamp":1698415638000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/clc.4960200104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1997,1]]}},"alternative-id":["10.1002\/clc.4960200104"],"URL":"https:\/\/doi.org\/10.1002\/clc.4960200104","archive":["Portico"],"relation":{},"ISSN":["0160-9289","1932-8737"],"issn-type":[{"value":"0160-9289","type":"print"},{"value":"1932-8737","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,1]]}}}